Skip to main content

Table 1 Perioperative variables in the non-aPRP group and aPRP group

From: Impact of autologous platelet rich plasma use on postoperative acute kidney injury in type A acute aortic dissection repair: a retrospective cohort analysis

Clinical variables

Non-aPRP Group(n = 388)

aPRP Group(n = 272)

P Value

 Age (year)

49.29 ± 10.60

47.52 ± 9.77

0.030

 Males, n (%)

305 (78.4)

230 (84.6)

0.067

 Height (cm)

172.05 ± 7.51

171.49 ± 8.02

0.359

 Weight (kg)

77.02 ± 13.16

78.8 ± 13.20

0.073

 BMI (kg/M2)

25.97 ± 3.75

26.75 ± 3.70

0.009

 History of smoking, n (%)

137 (35.2)

120 (44.1)

0.023

 History of hypertension, n (%)

294 (75.8)

199 (73.2)

0.448

 History of DM, n (%)

18 (4.6)

13 (4.8)

0.933

 Time from onset of symptoms to surgery (d)

2 (1,4)

2 (1, 4)

0.768

preoperative

 LVEF (%)

60.22 ± 6.52

60.58 ± 6.302

0.490

 LVEDd (mm)

50.76 ± 8.71

49.888 ± 7.8517

0.195

EuroSCORE

5 (4.5,5)

5 (5,5)

0.408

 HR (beats/min)

80 ± 15

80 ± 15

0.334

 MBP (mm Hg)

89 ± 18

85 ± 22

0.014

 Hb(g/L)

12.68 ± 2.63

13.91 ± 4.14

0.001

 WBC (109/L)

10.91 ± 4.11

11.38 ± 3.72

0.135

 PLC(109 /L)

151 ± 76

171 ± 64

0.001

 LAC (mmol/L)

1.52 ± 0.95

1.56 ± 0.87

0.549

 SCr (umol/L)

102.9 ± 53.1

82.6 ± 37.6

< 0.001

 PT (second)

12.74 ± 2.29

12.81 ± 2.06

0.727

 PTA(100%)

87.03 ± 14.44

84.67 ± 14.67

0.128

 APTT (second)

32.83 ± 11.51

31.70 ± 6.76

0.211

 FIB(g/L)

3.30 ± 1.49

3.21 ± 1.56

0.571

 FDP (mg/L)

18.65 (9.01,31.45)

19.2 (10.2,35.65)

0.329

 D-D (ug/L)

1581 (850, 2976)

1836 (808, 2719)

0.660

 INR

1.09 (1.03,1.18)

1.11 (1.04,1.19)

0.192

Intraoperative

 With CABG

13 (5.2)

16 (6.5)

0.537

 Duration of surgery (min)

465 ± 99

492 ± 105

0.001

 Duration of CPB (min)

271.49 ± 172.64

281.27 ± 152.09

0.453

 Duration of Aortic cross-clamping (min)

92.97 ± 56.01

86.95 ± 54.77

0.171

 Lowest rectal temperature (°C)

25.21 ± 2.13

25.21 ± 1.79

0.966

 Lowest nasopharyngeal temperature (°C)

22.46 ± 6.02

22.91 ± 6.60

0.363

 Intravenous crystalloid (mL)

2153 ± 887

2354 ± 1133

0.015

 Allogeneic Red blood cells (units)

0 (0, 4)

0 (0, 3)

0.012

 Allogeneic blood Plasma (mL)

200 (0, 600)

0 (0,400)

0.001

aBlood product transfused (ml)

520 (0,1040)

375 (0,975)

0.014

 Urine volume during surgery (mL)

1591 ± 1073

1643 ± 863

0.503

Postoperative

 LVEF (%)

59.68 ± 7.04

59.59 ± 6.57

0.870

 HR (beats/min)

93 ± 17

94 ± 16

0.384

 MBP (mmHg)

88 ± 19

86 ± 20

0.20

 Hb(g/L)

10.23 ± 1.86

10.42 ± 1.57

0.545

 WBC (109/L)

11.48 ± 4.86

12.15 ± 4.57

0.20

 PLC(109 /L)

106 ± 51

97 ± 62

0.14

 LAC (mmol/L)

2.79 ± 3.12

3.97 ± 3.93

<0.001

 PT (second)

13.77 ± 4.45

13.18 ± 2.39

0.080

 PTA(100%)

82.81 ± 15.72

81.56 ± 14.86

0.442

 APTT (second)

32.63 ± 7.13

33.10 ± 12.04

0.628

 FIB(g/L)

3.34 ± 1.43

3.39 ± 1.97

0.731

 FDP (mg/L)

19 (9.17,32.4)

17.56 (9.52,35.67)

0.929

 D-D (ug/L)

1963 (855,3046)

1619 (815,2841)

0.510

 INR

1.12 (1.04,1.24)

1.14 (1.06,1.24)

0.323

 SCr (umol/L)

118.58 ± 72.59

105.89 ± 51.50

0.011

Postoperative 24 h

 SCr (umol/L)

133.1 ± 91.8

115.2 ± 66.6

0.005

 Seroma volume of drainage (mL)

1472 ± 667

1539 ± 820

0.263

Postoperative 48 h

 SCr (umol/L)

136.1 ± 106.3

122.3 ± 98.2

0.102

Postoperative 72 h

 SCr (umol/L)

113.4 ± 93.7

110.1 ± 77.5

0.737

  1. Data are given as numbers, percentage, mean ± standard deviation or median (interquartile range, IQR). BMI Body mass index, DM Diabetes mellitus, LVEF Left ventricular ejection fraction, LVEDD Left ventricular end diastolic diameter, EuroSCORE European system for cardiac operative risk evaluation, MBP Mean blood pressure, PLC Platelet count, Hb Hemoglobin, WBC White blood cells, LAC Lactic acid, FIB Fibrinogen, FDP Fibrinogen degradation product, APTT Active part thrombin time, PT Prothrombin time, APTT Activated partial thromboplastin time, PTA Prothrombin activityprothrombin time activity, INR International normalized ratio, D-D D-Dimer, SCr Serum creatine, CABG Coronary artery bypass grafting, CPB Cardiopulmonary bypass. aNumber of blood products transfused perioperatively was defined as total units of red blood cells (1 unit = 160 ml), fresh-frozen plasma and apheresis platelet units (1 unit = 260 ml) administered